Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico. 2009

Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
División de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica, Camino a la Presa San José 2055, 78216 San Luis Potosí, SLP, Mexico. rlopez@ipicyt.edu.mx

BACKGROUND In San Luis Potosí City cervical infection by human papillomavirus type 16 (HPV16) associated to dysplastic lesions is more prevalent in younger women. In this work HPV16 subtypes and variants associated to low-grade intraepithelial lesions (LSIL), high-grade intraepithelial lesions (HSIL) and invasive cervical cancer (ICC) of 38 women residing in San Luis Potosí City were identified by comparing their E6 open reading frame sequences. RESULTS Three European (E) variants (E-P, n = 27; E-T350G, n = 7; E-C188G, n = 2) and one AA-a variant (n = 2) were identified among the 38 HPV16 sequences analyzed. E-P variant sequences contained 23 single nucleotide changes, two of which (A334G, A404T) had not been described before and allowed the phylogenetic separation from the other variants. E-P A334G sequences were the most prevalent (22 cases, 57.9%), followed by the E-P Ref prototype (8 cases, 21.1%) and E-P A404T (1 case, 2.6%) sequences. The HSIL + ICC fraction was 0.21 for the E-P A334G variants and 0.00 for the E-P Ref variants. CONCLUSIONS We conclude that in the women included in this study the HPV16 E subtype is 19 times more frequent than the AA subtype; that the circulating E variants are E-P (71.1%) > E-T350G (18.4%) > E-C188G (5.3%); that 71.0% of the E-P sequences carry the A334G single nucleotide change and appear to correspond to a HPV16 variant characteristic of San Luis Potosi City more oncogenic than the E-P Ref prototype.

UI MeSH Term Description Entries

Related Publications

Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
September 2020, Human immunology,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
January 2015, Infectious agents and cancer,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
January 2016, Infectious agents and cancer,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
July 1991, Gynecologic oncology,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
July 2005, The Pediatric infectious disease journal,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
November 1985, British journal of obstetrics and gynaecology,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
September 2004, Journal of medical virology,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
November 1966, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
May 2014, The Pediatric infectious disease journal,
Rubén López-Revilla, and Marco A Pineda, and Julio Ortiz-Valdez, and Mireya Sánchez-Garza, and Lina Riego
January 1987, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
Copied contents to your clipboard!